These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 14710019)

  • 1. [Neurological manifestations of leprosy].
    Grimaud J; Vallat JM
    Rev Neurol (Paris); 2003 Nov; 159(11):979-95. PubMed ID: 14710019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprous neuropathy.
    de Freitas MR; Said G
    Handb Clin Neurol; 2013; 115():499-514. PubMed ID: 23931798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
    Legendre DP; Muzny CA; Swiatlo E
    Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriately Selected Nerve in Suspected Leprous Neuropathy Yields High Positive Results for
    Vengalil S; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Polavarapu K; Mahajan NP; Raju S; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh B; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
    Am J Trop Med Hyg; 2020 Jul; 103(1):209-213. PubMed ID: 32285768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological manifestations of Hansen's disease and their management.
    Agrawal A; Pandit L; Dalal M; Shetty JP
    Clin Neurol Neurosurg; 2005 Oct; 107(6):445-54. PubMed ID: 16202816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
    Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
    Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leprosy, a neurologic disease].
    Coeytaux A; Truffert A; Mueller Y; Antille C; Jackson Y
    Rev Med Suisse; 2007 May; 3(110):1178, 1180-4. PubMed ID: 17564345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of leprous neuropathy in practice].
    Flageul B
    Rev Neurol (Paris); 2012 Dec; 168(12):960-6. PubMed ID: 23131313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
    Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
    Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peripheral nerve damage in patients with leprosy].
    Grimaud J
    Rev Neurol (Paris); 2012 Dec; 168(12):967-74. PubMed ID: 23107882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M; Mathan MM
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
    Lefford MJ; Hunegnaw M; Siwik E
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of leprosy/Hansen's disease in the early 21st century.
    Worobec SM
    Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical, immunological, and histological study of neuritic leprosy patients.
    Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
    Singal A; Sonthalia S; Pandhi D
    Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprous neuropathies.
    Waters MF; Jacobs JM
    Baillieres Clin Neurol; 1996 Mar; 5(1):171-97. PubMed ID: 8732207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leprosy. Pathogenesis--classification--diagnosis--treatment].
    Stingl P
    Hautarzt; 1990 Mar; 41(3):126-30. PubMed ID: 2188935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
    Shetty VP; Suchitra K; Uplekar MW; Antia NH
    Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprous neuromyositis: A rare clinical entity and review of the literature.
    Mitra S; Gunasekaran K; Chacko G; Hansdak SG
    Indian J Med Microbiol; 2016; 34(1):95-7. PubMed ID: 26776128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.